dc.contributor.author
Cabana Domínguez, Judit
dc.contributor.author
Roncero, Carlos
dc.contributor.author
Pineda Cirera, Laura
dc.contributor.author
Palma Álvarez, R. Felipe
dc.contributor.author
Ros Cucurull, Elena
dc.contributor.author
Grau-López, Lara
dc.contributor.author
Esojo, Abderaman
dc.contributor.author
Casas, Miquel
dc.contributor.author
Arenas Solà, Concepción
dc.contributor.author
Ramos Quiroga, Josep Antoni
dc.contributor.author
Ribasés Haro, Marta
dc.contributor.author
Fernàndez Castillo, Noèlia
dc.contributor.author
Cormand Rifà, Bru
dc.date.issued
2018-03-20T15:23:42Z
dc.date.issued
2018-03-20T15:23:42Z
dc.date.issued
2017-08-31
dc.date.issued
2018-03-20T15:23:42Z
dc.identifier
https://hdl.handle.net/2445/120920
dc.description.abstract
Genetic factors involved in the susceptibility to drug addiction still remain largely unknown. MiRNAs seem to play key roles in the drug-induced plasticity of the brain that likely drives the emergence of addiction. In this work we explored the role of miRNAs in drug addiction. With this aim, we selected 62 SNPs located in the 3'UTR of target genes that are predicted to alter the binding of miRNA molecules and performed a case-control association study in a Spanish sample of 735 cases (mainly cocaine-dependent subjects with multiple drug dependencies) and 739 controls. We found an association between rs1047383 in the PLCB1 gene and drug dependence that was replicated in an independent sample (663 cases and 667 controls). Then we selected 9 miRNAs predicted to bind the rs1047383 region, but none of them showed any effect on PLCB1 expression. We also assessed two miRNAs binding a region that contains a SNP in linkage disequilibrium with rs1047383, but although one of them, hsa-miR-582, was found to downregulate PLCB1, no differences were observed between alleles. Finally, we explored the possibility that PLCB1 expression is altered by cocaine and we observed a significant upregulation of the gene in the nucleus accumbens of cocaine abusers and in human dopaminergic-like neurons after cocaine treatment. Our results, together with previous studies, suggest that PLCB1 participates in the susceptibility to drug dependence.
dc.format
application/pdf
dc.publisher
Nature Publishing Group
dc.relation
Reproducció del document publicat a: https://doi.org/10.1038/s41598-017-10207-2
dc.relation
Scientific Reports, 2017, vol. 7, num. 10110
dc.relation
https://doi.org/10.1038/s41598-017-10207-2
dc.relation
info:eu-repo/grantAgreement/EC/H2020/667302/EU//CoCA
dc.relation
info:eu-repo/grantAgreement/EC/FP7/602805/EU//AGGRESSOTYPE
dc.rights
cc-by (c) Cabana Domínguez, Judit et al., 2017
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject
Sistema nerviós
dc.subject
Drug addiction
dc.subject
Nervous system
dc.title
Association of the PLCB1 gene with drug dependence
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion